{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T15:24:44Z","timestamp":1725722684373},"reference-count":25,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,10,29]]},"DOI":"10.7759\/cureus.47932","type":"journal-article","created":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T05:52:00Z","timestamp":1698645120000},"source":"Crossref","is-referenced-by-count":1,"title":["A Comparative Study on Survivors Versus Non-Survivors Among Diabetic Patients Having Mucormycosis"],"prefix":"10.7759","author":[{"given":"Anbumathi","family":"S","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karthikeyan","family":"Govindarajan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yogesh","family":"S","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pranav Lokesh G","family":"Parivallal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sathyanarayana","family":"Hariharan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atif","family":"Khaleel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Praveen T","family":"SB","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katyayani","family":"Goswami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pushpa","family":"Saravanan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dharmarajan","family":"Panneerselvam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s12223-021-00934-5","article-title":"Mucormycosis: risk factors, diagnosis, treatments, and challenges during COVID-19 pandemic","volume":"67","author":"Sharma A","year":"2022","unstructured":"Sharma A, Goel A. Mucormycosis: risk factors, diagnosis, treatments, and challenges during COVID-19 pandemic. Folia Microbiol. 2022, 67:363-87. 10.1007\/s12223-021-00934-5","journal-title":"Folia Microbiol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(19)30312-3","article-title":"Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium","volume":"19","author":"Cornely OA","year":"2019","unstructured":"Cornely OA, Alastruey-Izquierdo A, Arenz D, et al.. Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium. Lancet Infect Dis. 2019, 19:e405-21. 10.1016\/S1473-3099(19)30312-3","journal-title":"Lancet Infect Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.18827","article-title":"Risk of mucormycosis in diabetes mellitus: a systematic review","volume":"13","author":"Khanna M","year":"2021","unstructured":"Khanna M, Challa S, Kabeil AS, et al.. Risk of mucormycosis in diabetes mellitus: a systematic review. Cureus. 2021, 13:e18827. 10.7759\/cureus.18827","journal-title":"Cureus"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/jof5010026","article-title":"Global epidemiology of Mucormycosis","volume":"5","author":"Prakash H","year":"2019","unstructured":"Prakash H, Chakrabarti A. Global epidemiology of Mucormycosis. J Fungi (Basel). 2019, 5:10.3390\/jof5010026","journal-title":"J Fungi (Basel)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2021.05.019","article-title":"Mucormycosis in COVID-19: a systematic review of cases reported worldwide and in India","volume":"15","author":"Singh AK","year":"2021","unstructured":"Singh AK, Singh R, Joshi SR, Misra A. Mucormycosis in COVID-19: a systematic review of cases reported worldwide and in India. Diabetes Metab Syndr. 2021, 15:102146. 10.1016\/j.dsx.2021.05.019","journal-title":"Diabetes Metab Syndr"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2174\/1573399818666220224123525","article-title":"Impact of diabetes in COVID-19 associated mucormycosis and its management: a non-systematic literature review","volume":"19","author":"Rashid M","year":"2023","unstructured":"Rashid M, Rajan AK, Thunga G, Shanbhag V, Nair S. Impact of diabetes in COVID-19 associated mucormycosis and its management: a non-systematic literature review. Curr Diabetes Rev. 2023, 19:e240222201411. 10.2174\/1573399818666220224123525","journal-title":"Curr Diabetes Rev"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.35095","article-title":"Spotlight on the mucormycosis outbreak: a deadly fungal infection that followed the COVID-19 pandemic","volume":"15","author":"Patel SN","year":"2023","unstructured":"Patel SN, Shah S, Panchal J, Desai C, Upadhya IB, Patel M. Spotlight on the mucormycosis outbreak: a deadly fungal infection that followed the COVID-19 pandemic. Cureus. 2023, 15:e35095. 10.7759\/cureus.35095","journal-title":"Cureus"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/jof7040298","article-title":"When uncontrolled diabetes mellitus and severe COVID-19 converge: the perfect storm for mucormycosis","volume":"7","author":"John TM","year":"2021","unstructured":"John TM, Jacob CN, Kontoyiannis DP. When uncontrolled diabetes mellitus and severe COVID-19 converge: the perfect storm for mucormycosis. J Fungi (Basel). 2021, 7:298. 10.3390\/jof7040298","journal-title":"J Fungi (Basel)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.2337\/db16-0806","article-title":"Differentiation of diabetes by pathophysiology, natural history, and prognosis","volume":"66","author":"Skyler JS","year":"2017","unstructured":"Skyler JS, Bakris GL, Bonifacio E, et al.. Differentiation of diabetes by pathophysiology, natural history, and prognosis. Diabetes. 2017, 66:241-55. 10.2337\/db16-0806","journal-title":"Diabetes"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1017\/dmp.2021.111","article-title":"Rollout of COVID-19 vaccination in India: a SWOT analysis","author":"Sharma P","year":"2021","unstructured":"Sharma P, Pardeshi G. Rollout of COVID-19 vaccination in India: a SWOT analysis. Disaster Med Public Health Prep. 2021, 1-4. 10.1017\/dmp.2021.111","journal-title":"Disaster Med Public Health Prep"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciac398","article-title":"Coronavirus disease 2019 (COVID-19) vaccine prioritization in low- and middle-income countries may justifiably depart from high-income countries\u2019 age priorities","volume":"75","author":"Eyal N","year":"2022","unstructured":"Eyal N, Gheaus A, Gosseries A, et al.. Coronavirus disease 2019 (COVID-19) vaccine prioritization in low- and middle-income countries may justifiably depart from high-income countries\u2019 age priorities. Clin Infect Dis. 2022, 75:S93-7. 10.1093\/cid\/ciac398","journal-title":"Clin Infect Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.4149\/BLL_2022_068","article-title":"Risk factors and the impact of vaccination on mortality in COVID-19 patients","volume":"123","author":"Sezen YI","year":"2022","unstructured":"Sezen YI, Senoglu S, Karabela SN, et al.. Risk factors and the impact of vaccination on mortality in COVID-19 patients. Bratisl Lek Listy. 2022, 123:440-3. 10.4149\/BLL_2022_068","journal-title":"Bratisl Lek Listy"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2021.106231","article-title":"Cerebrovascular involvement in mucormycosis in COVID-19 pandemic","volume":"31","author":"Kulkarni R","year":"2022","unstructured":"Kulkarni R, Pujari SS, Gupta D, et al.. Cerebrovascular involvement in mucormycosis in COVID-19 pandemic. J Stroke Cerebrovasc Dis. 2022, 31:106231. 10.1016\/j.jstrokecerebrovasdis.2021.106231","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.4103\/ijo.IJO_1565_21","article-title":"Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India - Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1","volume":"69","author":"Sen M","year":"2021","unstructured":"Sen M, Honavar SG, Bansal R, et al.. Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India - Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1. Indian J Ophthalmol. 2021, 69:1670-92. 10.4103\/ijo.IJO_1565_21","journal-title":"Indian J Ophthalmol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.4103\/0970-2113.148452","article-title":"Pulmonary tuberculosis and mucormycosis co-infection in a diabetic patient","volume":"32","author":"Aggarwal D","year":"2015","unstructured":"Aggarwal D, Chander J, Janmeja AK, et al.. Pulmonary tuberculosis and mucormycosis co-infection in a diabetic patient. Lung India. 2015, 32:53-55. 10.4103\/0970-2113.148452","journal-title":"Lung India"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/s43088-021-00165-0","article-title":"Corticosteroids for treatment of COVID-19: effect, evidence, expectation and extent","volume":"10","author":"Patel VK","year":"2021","unstructured":"Patel VK, Shirbhate E, Patel P, Veerasamy R, Sharma PC, Rajak H. Corticosteroids for treatment of COVID-19: effect, evidence, expectation and extent. Beni Suef Univ J Basic Appl Sci. 2021, 10:78. 10.1186\/s43088-021-00165-0","journal-title":"Beni Suef Univ J Basic Appl Sci"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2021.102322","article-title":"COVID-19 associated mucormycosis: a descriptive multisite study from India","volume":"15","author":"Gupta R","year":"2021","unstructured":"Gupta R, Kesavadev J, Krishnan G, et al.. COVID-19 associated mucormycosis: a descriptive multisite study from India. Diabetes Metab Syndr. 2021, 15:102322. 10.1016\/j.dsx.2021.102322","journal-title":"Diabetes Metab Syndr"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.4103\/ijo.IJO_340_22","article-title":"Analysis of COVID-19-associated rhino-orbital-cerebral mucormycosis patients in a tertiary care center in Northern India","volume":"70","author":"Yadav H","year":"2022","unstructured":"Yadav H, Sen S, Nath T, Mazumdar S, Jain A, Verma P, Gupta P. Analysis of COVID-19-associated rhino-orbital-cerebral mucormycosis patients in a tertiary care center in Northern India. Indian J Ophthalmol. 2022, 70:2163-8. 10.4103\/ijo.IJO_340_22","journal-title":"Indian J Ophthalmol"},{"key":"ref19","article-title":"Rhino-Orbital Cerebral Mucormycosis","author":"AK AK","year":"2023","unstructured":"AK AK, Gupta V. Rhino-Orbital Cerebral Mucormycosis. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2023."},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-5247(21)00237-8","article-title":"The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries","volume":"3","author":"Hoenigl M","year":"2022","unstructured":"Hoenigl M, Seidel D, Carvalho A, et al.. The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries. Lancet Microbe. 2022, 3:e543-52. 10.1016\/S2666-5247(21)00237-8","journal-title":"Lancet Microbe"},{"key":"ref21","article-title":"Mucormycosis and COVID-19: risk factors, clinical presentation and outcome in a tertiary care centre in North India","volume":"70","author":"A GA","year":"2022","unstructured":"A GA, Ashraf H, HaiderMehdi HS. Mucormycosis and COVID-19: risk factors, clinical presentation and outcome in a tertiary care centre in North India. J Assoc Physicians India. 2022, 70:11-12.","journal-title":"J Assoc Physicians India"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1007\/s13760-021-01840-w","article-title":"Mucormycosis in COVID-19 patients: predisposing factors, prevention and management","volume":"122","author":"Rudrabhatla PK","year":"2022","unstructured":"Rudrabhatla PK, Reghukumar A, Thomas SV. Mucormycosis in COVID-19 patients: predisposing factors, prevention and management. Acta Neurol Belg. 2022, 122:273-80. 10.1007\/s13760-021-01840-w","journal-title":"Acta Neurol Belg"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2021.111643","article-title":"Mucormycosis: an opportunistic pathogen during COVID-19","volume":"201","author":"Mahalaxmi I","year":"2021","unstructured":"Mahalaxmi I, Jayaramayya K, Venkatesan D, et al.. Mucormycosis: an opportunistic pathogen during COVID-19. Environ Res. 2021, 201:111643. 10.1016\/j.envres.2021.111643","journal-title":"Environ Res"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(21)00442-2","article-title":"Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID study","volume":"10","author":"Gangneux JP","year":"2022","unstructured":"Gangneux JP, Dannaoui E, Fekkar A, et al.. Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID study. Lancet Respir Med. 2022, 10:180-90. 10.1016\/S2213-2600(21)00442-2","journal-title":"Lancet Respir Med"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms10061209","article-title":"Mucormycosis in COVID-19 patients: a case-control study","volume":"10","author":"Pandit AK","year":"2022","unstructured":"Pandit AK, Tangri P, Misra S, et al.. Mucormycosis in COVID-19 patients: a case-control study. Microorganisms. 2022, 10:10.3390\/microorganisms10061209","journal-title":"Microorganisms"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/197428-a-comparative-study-on-survivors-versus-non-survivors-among-diabetic-patients-having-mucormycosis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:09:28Z","timestamp":1707509368000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/197428-a-comparative-study-on-survivors-versus-non-survivors-among-diabetic-patients-having-mucormycosis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,29]]},"references-count":25,"URL":"https:\/\/doi.org\/10.7759\/cureus.47932","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10,29]]}}}